Chronic Illness

Mycotoxins

Toxins

TH1 and TH2 Shifit + Ozone Therapy in Chronic Illness

Mycotoxin and Chronic illness Summit 2022

<h6>Eric D. Gordon, M.D.</h6>
Welcome. Welcome to another edition of Mycotoxins and Chronic Illness. This is 2.0. We&#8217;re here again. And this time, we&#8217;ll have a chance to talk to Dr. Frank Shallenberger. Dr. Shallenberger is just a very important man in my life, &#8217;cause he&#8217;s the person who really helped teach me about ozone and make me realize how important it is in all of its many uses. He&#8217;s also inspired me to really pay attention to the mitochondria. And we&#8217;re gonna talk a little bit about both of those today, but we&#8217;re gonna concentrate on Dr. Shallenberger&#8217;s approach to chronic infections and how he looks at this. Something that&#8217;s been an interest of his for a long time. And I think he wrote his first paper about it in the late nineties. So, without further ado, welcome, Dr. Shallenberger. And pleasure to have you with us. And so tell me what got you interested, actually I&#8217;m gonna start with what got you interested in chronic illnesses in the first place?
&nbsp;

https://drsummits.s3.us-west-1.amazonaws.com/2022+Summits/Mycotoxins+and+Chronic+Illness+Summit+/Transcript+Files/Mycotoxins+_+Chronic+Illness+Summit+2022-Frank+Shallenberger%2C+MD%2C+HMD+Transcript+File.pdf

Dr. Shallenberger has been practicing frontline medicine since 1973. In the early 80s he began using ozone therapy as a treatment for infectious diseases not responsive to conventional approaches. He published a peer reviewed paper in 1998 in which he described his theory that non-responsive chronic infectious diseases are primarily due to a shift in the immune response from a TH1 response to a TH2 response. This shift is primarily due to vaccines, recreational and prescribed drugs, petrochemicals, mold, blood transfusions, and parasites. Ozone therapy, along with other immune modulating nutritional and herbal therapies is able to shift a primary TH2 immune response back to a healthy TH1 response, and is therefore instrumental to correcting chronic infectious illnesses.

Frank Shallenberger, MD, HMD, ABAAM

Eric Gordon, MD is President of Gordon Medical Research Center and clinical director of Gordon Medical Associates which specializes in complex chronic illness. In addition to being in clinical practice for over 40 years, Dr. Gordon is engaged in clinical research focused on bringing together leading international medical researchers and cutting-edge clinicians. His research is focusing on ME/CFS, Lyme disease, autoimmune diseases, and autism.

TH1 and TH2 Shifit + Ozone Therapy in Chronic Illness

Eric Gordon, MD

Frank Shallenberger, MD, HMD, ABAAM

Summary

Content Provided By

Eric Gordon, MD

Guest Experts

Frank Shallenberger, MD, HMD, ABAAM